AWC®: ESD+ technique for the resection of 4-cm recurrent rectal intramucosal adenocarcinoma led to good ...
AWC®: ESD+ technique for the resection of 4-cm recurrent rectal intramucosal adenocarcinoma led to good ...
We are very proud to announce that our products OTSC® System and mini OTSC® System ...
A systematic review evaluating 9 studies with overall 107 patients who underwent closure of anastomotic ...
A study analyzing data of two referral pediatric endoscopy units identified 24 OTSC applications in ...
An internal evaluation of the delivery capability and speed to our German, French and US ...
Multicenter RCT published in Gut – STING 2 trial on first line hemostasis shows superiority ...
AWC®: ESD+ technique for the resection of 4-cm recurrent rectal intramucosal adenocarcinoma led ...
We are very proud to announce that our products OTSC® System and mini OTSC® System ...
A systematic review evaluating 9 studies with overall 107 patients who underwent closure of ana ...
A study analyzing data of two referral pediatric endoscopy units identified 24 OTSC application ...
An internal evaluation of the delivery capability and speed to our German, French and US ...
Multicenter RCT published in Gut – STING 2 trial on first line hemostasis shows superiority ...
stentfix OTSC®: 76.5% relative risk reduction of SEMS migration associated with utilization of ...
We, Ovesco Endoscopy AG, have been awarded the employer seal „Leading Employer“. This cross-ind ...
A comparison study on OTSC® vs standard endoscopic therapy as first-line treatment in ulcers wi ...
Ovesco is currently working to bring you a more comprehensive offer of digital communication. W ...
A comparison study of patients with colonic neoplastic lesions ≤ 30 mm, who underwent either ...
With our membership in the Gastroenterology Foundation e.V., we support the establishment of en ...
HemoPill® acute and HemoPill® monitor are promising technologies for the detection of blood/hem ...
A case report describes the successful removal of a 22 mm non-granular laterally spreading acro ...
The guideline recommends first-line OTSC® therapy for esophageal perforation 1 – 2 cm in size, ...
Ovesco helps patients with gastrointestinal diseases in South Africa with free delivery of inno ...
The joint Annual Meeting of the German Society for Gastroenterology, Digestive and Metabolic Di ...
Two major RCTs investigating the OTSC system in first-line therapy were presented at this year& ...
A systematic review of studies evaluating OTSC application for repair of iatrogenic perforation ...
The retrospective analysis included overall 20 patients with type I duodenal perforation. 8 pat ...
A retrospective cohort study of 17 patients undergoing hybrid EMR-FTRD for large colorectal les ...
The use of the HemoPill acute demonstrated its ability to reliably detect or exclude bleeding ...
65 consecutive patients underwent EFTR of colorectal lesions, either via stand-alone EFTR (lesi ...
A multicenter retrospective analysis of 50 patients undergoing EFTR for colonic lesions involvi ...
Conference report of the Digestive Disease Week (DDW) 2021 The conference of the Digestive Dise ...
A cohort study of 50 patients with symptomatic eosinophilic esophagitis treated with a single d ...
Ovesco’s first wireless sensor capsule for detection of upper and middle gastrointestinal ...
Tuebingen, Germany, June 30th, 2021 – Frank Ramsperger, Chairman of the Supervisory Board of Ov ...
A new dimension in endoscopic grasping: the OTSG Xcavator™ The removal of hard to grasp ...
The 50th Congress of the German Society for Endoscopy and Imaging Techniques e.V. (DGE-BV) took ...
Preliminary results from RCT study show that OTSC first-line treatment is superior to standard ...
OTSC® is recommended in current guidelines for the first-line treatment of large ulcers and the ...
Based on an R&D data survey by the Stifterverband, Ovesco has qualified to receive the ...
The 50th Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) took pl ...
FTRD application in 56 patients with lesions in the upper GI tract showed a technical ...
We are represented at the EndoAIMS Hands-On Training, April 8, 2021. It is a great ...
Ovesco Endoscopy AG seizes new opportunities through digital transformation for its workflow in ...
HemoPill® acute for gastrointestinal diagnosis and its future clinical routine – an Interview ( ...
We are honored to present the highlights (17 mins) of our webinar “Turn Challenges Into ...
A systematic review of studies with at least five patients examinating OTSC application for any ...
Evaluation of the “German colonic FTRD registry” comprising 1178 colorectal FTRD procedures fro ...
A prospective multicenter study analyzing the data of the Dutch colorectal eFTR registry compri ...
Colonic OTSC placement was mostly performed in patients undergoing polypectomy (62.4 %), but al ...
53 patients with NVUGIB were randomized to OTSC hemostasis or standard endoscopic treatment. Re ...
Insights from 10 speakers and best practice example of empowering high potentials We are honour ...
Ovesco is proud to announce that LiftUp® has received market approval in Saudi Arabia. It ...
Cold-Endoscopic Submucosal Dissection (C-ESD) was performed in live porcine models. 12 C-ESDs w ...
Ovesco’s first wireless sensor capsule for detection of upper and middle gastrointestinal ...
Conference Report of the United European Gastroenterology Week (UEGW) 2020: HemoPill® acute det ...
Compared to patients treated with transcatheter arterial embolization (TAE) for refractory pept ...
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with ...
The novel EMR+ technique uses an external additional working channel (AWC®) allowing for tissue ...
In 46 POEM and 26 G-POEM procedures, OTSC closure of the entry site was related ...
The novel ESD+ technique uses the external additional working channel (AWC®), which allows for ...
Ovesco is proud to announce that the colonic and diagnostic FTRD® have received market approval ...
OTSC application is recommended for esophageal iatrogenic perforation > 10 mm, for gastric i ...
In the context of the DGVS 2019 we have started our donation project to provide ...
A meta-analysis comprising 18 studies with overall 730 patients with difficult gastrointestinal ...
A cost analysis based on mathematic modelling determined the average cost of repeating standard ...
Ovesco Endoscopy awarded TOP 10 MEDICAL DIAGNOSTICS Solution Providers 2020 Ovesco Endoscopy ha ...
Prof. Alexander Meining, Interventional and Experimental Endoscopy (InExEn), Internal Medicine ...
Expand your horizon on resection techniques in endoluminal surgery. This was the underlying top ...
stentfix OTSC was used in five complex cases who already had experienced stent migration and ...
92 patients with 117 non-acute full-thickness gastrointestinal defects (65 fistulas, 52 leaks) ...
Resection techniques in endoluminal surgery July 15th, 2020, 4 – 5.30 pm CET Expand your ...
The novel submucosal injection agent LiftUp was successfully used in a first clinical case seri ...
The patient had experienced esophageal perforation due to bougienage with a through-the-scope b ...
Ovesco is proud to announce that the gastroduodenal FTRD® has been cleared for marketing by ...
Conference report of the Digestive Disease Week (DDW) 2020 FTRD® System: EFTR enables new thera ...
106 patients with perforated peptic ulcer were treated with OTSC (n = 26) or conservative ...
The document reviews current techniques and devices used for EFTR, clinical applications and ou ...
16 patients with rectovaginal fistulas, 13 of those having undergone previous surgical interven ...
In lesions > 2 cm, EMR+ outdoes its advantages: comparative trial demonstrates en-bloc resec ...
Ovesco is proud to announce that LiftUp® has received market approval in Australia and New ...
Because of its tissue apposition capabilities and easy en face application, OTSC is used as ...
In 7/10 patients with enterocutaneous fistula, OTSC application resulted in complete fistula cl ...
Conference Report of the American College of Gastroenterology (ACG) 2019: OTSC®: Besides a RCT ...
„Everyone is just talking about it – ovesco does it“ – thanks to ARKTIK, climate-neutral ...
In 40 patients with rectal neuroendocrine tumors (NETs), EFTR resulted in 100 % macroscopically ...
In 851 patients from 21 studies, definitive hemostasis was reached in 87.8 %, technical success ...
Ovesco has been able to achieve a large growth in turnover and employees in recent ...
Within the scope of the joint research project ‘nuEndo’, Ovesco Endoscopy AG is wor ...
In 96 patients with complex anorectal fistulas, OTSC Proctology application lead to an overall ...
Ovesco is proud to announce that LiftUp® has received market approval in Australia and New ...
„Everyone is just talking about it – ovesco does it“ – thanks to ARKTIK, climate-neutral ...
Conference Report of the United European Gastroenterology Week (UEGW) 2019: OTSC® shows superio ...
A randomized controlled trial presented at the American College of Gastroenterology (ACG) meeti ...
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with ...
Ovesco Endoscopy AG partnered in an innovative training network focusing on “Wireless in-body e ...
In 156 patients with histologic evidence of adenocarcinoma, EFTR was technically successful in ...
Ovesco Endoscopy is pleased to announce that the stentfix OTSC® System Set has received market ...
The Gastrointestinal Endoscopy Editorial Board chooses resection techniques namely EMR/submucos ...
EFTR in 30 patients with recurrent / residual colorectal neoplasia led to R0 resection in ...
The medical technology company located in Tuebingen will officially inaugurate its new building ...
The novel EMR+ technique uses an external additional working channel (AWC®) and a poloxamer age ...
Ovesco Endoscopy AG donates € 3,314.05 to “Help for Sick Children”, the charity at the Tübingen ...
When compared to fistulectomy and primary sphincter reconstruction, the OTSC Proctology showed ...
To err is human – to help is, too! Due to a missed exhibition stand ...
In 50 patients with complex benign esophageal stenoses, endoscopic bougienage with the BougieCa ...
For Ovesco Endoscopy AG, product innovation is among their core competences. Within the framewo ...
Gastric EFTR in 29 patients with gastric SET led to en-bloc resection in 89.7 %, ...
Digestive Disease Week – DDW 2019: – National and international multicenter studies confi ...
On the occasion of the 1st Family Day in the new building, the ovesco Endoscopy ...
German Coloproctology-Congress of the German Society for Coloproctology (Deutsche Gesellschaft ...
93 % primary hemostasis was achieved with primary OTSC therapy (288 patients), 91 % with ...
In lesions of 3 cm, EMR+ reaches its best discriminatory power: R0 resection rate of ...
Technical success (lesion reached and resected) was achieved in 94.4 %. R0 resection was achiev ...
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) 2019 together wi ...
After moving to its new company headquarters in the Technology Park Tuebingen at the beginning ...
Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 % ...
ovesco Endoscopy AG moved to its new headquarters on April 29, 2019 and will thus ...
Prospective data from 51 FTRD-procedures shows technical success in 88 % (45/51) and a R0-resec ...
The AWC was used in 8 patients with GI lesions 17-45 mm (average 35.9 mm) ...
Ovesco is proud to announce that both the OTSC® System and the remOVE System including ...
6 consecutive T1-ERC patients underwent FTRD application which resulted in complete endoscopic ...
EFTR of duodenal lesions in 20 patients showed technical success in 17/20 (85.0 %), a ...
96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower ...
Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success ...
Italian single-center study of 20 consecutive patients with non-lifting lesions, adenoma recurr ...
Ovesco Endoscopy AG merges all business entities in the Americas into its Ovesco Endoscopy USA ...
OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical suc ...
In a multicentric cohort of 100 consecutive patients with mean age 72 y, 51 % ...
Stuttgart, December 11, 2018 – Three medical technology companies of Tübingen receive the famil ...
OTSC use decreased the rebleeding rate in high-risk (RS ≥ 8) patients with statistical signific ...
Conference Report of the United European Gastroenterology Week (UEGW) 2018: RESECT+: additional ...
All 19 patients were treated successfully with the OTSC System. In 74 % of cases, ...
Multicenter study shows high technical success rate and significant improvement of dysphagia sy ...
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with ...
100 % primary hemostasis rate and improved management of rebleeding with OTSC® used as first ...
87.9 % R0-resection of non-lifting and submucosal colonic lesions with FTRD® Aepli P et al., ...
66.6 % of patients with leaking from the “J” of the tip of an ileo-anal ...
Dr Wedi received the DGVS endoscopy research award for the FLETRock study, a multi-centric stud ...
Bauder M et al., Department of Gastroenterology and Oncology, Ludwigsburg Hospital, Ludwigsburg ...
A systematic literature review evaluating efficacy and safety of the OTSC System in the managem ...
Kobara H and colleagues, Department of Gastroenterology and Neurology, Faculty of Medicine, Kag ...
Raithel M and colleagues, Department of Medicine II, University Erlangen, Germany presented dat ...
As part of the “Tübinger Klimaschutzpakt” the Ovesco Endoscopy AG contributes to climate protec ...
Ovesco is proud to announce that the OTSC® System including the OTSC® Anchor and the ...
Mizrahi I and colleagues, Digestive Disease Institute, Cleveland Clinic Florida, Weston, FL, US ...
Honegger C and colleagues, Division of Gastroenterology and Hepatology, University Hospital Zur ...
Gianfranco G. et al., Interventional Endoscopy Unit, Hospital Privé des Peupliers, Paris, Franc ...
OTSC has long been described in the scientific literature as a highly effective device for ...
Valli and colleagues, Division of Gastroenterology and Hepatology, Zurich University Hospital, ...
Ovesco welcomes following new distribution partners: Biogene Pharma Limited, a leading distribu ...
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) together with th ...
Prof Dr Alexander Meining, Department of Interventional and Experimental Endoscopy, University ...
Within the scope of the Annual Meeting of the Chilean – Germany Chamber of Commerce ...
A. Braun and H. Dawson, Gastroenterology and Endoscopy, SRO Langenthal, Switzerland and Institu ...
The 48th Conference of the German Society for Endoscopy and Imaging Procedures (Deutsche Gesell ...
El Douaihy Y et al., Department of Internal Medicine, Staten Island University Hospital – ...
PD Dr Schmidt, Department of Inner Medicine II, Gastroenterology, Hepatology, Endocrinology and ...
J Brandler and colleagues, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, ...
Ovesco is proud to announce the launch of the BougieCap. A new method for the ...
Ovesco announces that the remOVE System has been cleared by the US Food and Drug ...
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD ...
One of Germany’s first innovation awards, the state innovation award Baden-Württemberg – Dr.-Ru ...
Ovesco is proud to announce that OTSC has received market approval in Peru. The product ...
Mangiafico S et al., Azienda Ospedaliero, University of Modena, Italy, presented at the 25th UE ...
Chan SM and Lau JYW, Prince of Wales Hospital, The Chinese University of Hong Kong, ...
Ovesco is proud to announce that OTSC has received market approval in Taiwan. The product ...
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with ...
Devan Kizhakee – new Commercial Director MEA, Australasia Devan Kizhakee Kurichyath has a ...
In July Ovesco Endoscopy celebrated their groundbreaking ceremony for its new corporate headqua ...
Schmidt A, Beyna T, Schumacher B et al., affiliated to different German hospitals (Ludwigsburg, ...
Business news magazine brand eins rates Ovesco Endoscopy among the most innovative German compa ...
Innovative BougieCap and resection method developed in cooperation with Ovesco, randomized cont ...
Tübingen, July 19, 2017 – Groundbreaking ceremony marks beginning of construction Das Tübinger ...
Ovesco publishes an updated OTSC® update containing further relevant publications on research c ...
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD ...
Xiao X and Lau JY, Department of Surgery, Chinese University of Hong Kong, Hong Kong, ...
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD ...
Within the scope of the Annual Meeting of the British Society for Gastroenterology (BSG) from ...
R Manta et al., Niguarda-Ca Granda Hospital, Milan, Nuovo S. Agostino Hospital, Modena, Nuovo R ...
Within the scope of the DGE-BV / Endoscopy Live Congress in Berlin, the afternoon symposium ...
Dr. Malay Sharma from North India received the audiovisual award for the use of the ...
Dr. Schmidt, Department of Inner Medicine, Gastroenterology, Hemato-Oncology, Diabetology and I ...
The internet platform Endoscopy Campus is providing the latest information about endoscopy. Tog ...
HJ Richter-Schrag and colleagues, Center of Interdisciplinary Gastrointestinal Endoscopy and De ...